↓ Skip to main content
AI Standard of Care
  1. Tags/

IDx-DR

Ophthalmology AI Standard of Care: Diabetic Retinopathy, Glaucoma Detection, and Liability

··10 mins
Healthcare Ophthalmology AI Diabetic Retinopathy LumineticsCore IDx-DR Glaucoma AI AMD Detection FDA Devices Malpractice Standard of Care Autonomous AI
AI Revolutionizes Eye Disease Detection # Ophthalmology became the proving ground for autonomous AI in medicine when the FDA cleared the first-ever fully autonomous AI diagnostic system:IDx-DR (now LumineticsCore), in 2018. Today, AI systems can diagnose diabetic retinopathy at the point of care without a specialist, detect early signs of glaucoma and age-related macular degeneration (AMD), and guide treatment decisions. But with autonomy comes unprecedented liability questions: When AI screens for diabetic retinopathy in a primary care office and misses disease, who bears responsibility?